A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitors. Ekanayake P, Mudaliar S. Diabetes Obes Metab 2022;24:3-11.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ekanayake P, Mudaliar S. A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitors. Diabetes Obes Metab 2022;24:3-11.
PMID: 34605129